Semaglutide-induced weight loss improves mitochondrial energy efficiency in skeletal muscle
Authors:
- Cesar A. MezaCMCesar A. Meza
- Katsuhiko FunaiKatsuhiko Funai
Preprint
Abstract
Objective: Glucagon-like peptide 1 receptor agonists (e.g. semaglutide) potently induce weight loss and thereby reducing obesity-related complications. However, weight regain occurs when treatment is discontinued. An increase in skeletal muscle oxidative phosphorylation (OXPHOS) efficiency upon diet-mediated weight loss has been described, which may contribute to reduced systemic energy expenditure and weight regain. We set out to determine the unknown effect of semaglutide on muscle OXPHOS efficiency. Methods: C57BL/6J mice were fed a high-fat diet for 12 weeks before receiving semaglutide or vehicle for 1 or 3 weeks. The rate of ATP production and O 2 consumption were measured by a high-resolution respirometry and fluorometry to determine OXPHOS efficiency in skeletal muscle at these 2 timepoints. Results: Semaglutide treatment led to significant reductions in fat and lean mass. Semaglutide improved skeletal muscle OXPHOS efficiency, measured as ATP produced per O 2 consumed (P/O) in permeabilized muscle fibers. Mitochondrial proteomic analysis revealed changes restricted to two proteins linked to complex III assembly (Lyrm7 and Ttc1, p <0.05 without multiple corrections) without substantial changes in the abundance of OXPHOS subunits. Conclusions: These data indicate that weight loss with semaglutide treatment increases skeletal muscle mitochondrial efficiency. Future studies could test whether it contributes to weight regain.Keywords
All Related Versions
- Published version: Obesity, 33 (5), 974.
This publication has 42 references indexed in Scilit:
- Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonismMolecular Metabolism, 2024
- Need for speed: Human fast-twitch mitochondria favor power over efficiencyMolecular Metabolism, 2023
- Multifocal cavitating leukodystrophy–A distinct image in mitochondrial LYRM7 mutationsMultiple Sclerosis and Related Disorders, 2021
- TTC19 Plays a Husbandry Role on UQCRFS1 Turnover in the Biogenesis of Mitochondrial Respiratory Complex IIIMolecular Cell, 2017
- Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and OverCurrent Obesity Reports, 2017
- Enhanced Respiratory Chain Supercomplex Formation in Response to Exercise in Human Skeletal MuscleCell Metabolism, 2017
- Persistent metabolic adaptation 6 years after “The Biggest Loser” competitionObesity, 2016
- Analysis of Mitochondrial Respiratory Chain Supercomplexes Using Blue Native Polyacrylamide Gel Electrophoresis (BN‐PAGE)Current Protocols in Mouse Biology, 2016
- A Homozygous Mutation inLYRM7/MZM1LAssociated with Early Onset Encephalopathy, Lactic Acidosis, and Severe Reduction of Mitochondrial ComplexIIIActivityHuman Mutation, 2013
- LYRM7/MZM1L is a UQCRFS1 chaperone involved in the last steps of mitochondrial Complex III assembly in human cellsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2013